Managed Care Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
CHU Vaudois, Lausanne
Results highlight the importance of aspirin therapy compliance
October 9th, 2005
Researchers have investigated the effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. According to recent research from Switzerland, "Aspirin, or acetylsalicylic acid, is widely used to prevent ischemic vascular disease. Clinical and experimental data suggest that a rebound effect occurs 4 or fewer weeks after interruption of aspirin therapy." A.B. Maulaz and colleagues of the CHU in Vaudois wrote, "[Our aim was] to study the discontinuation of aspirin therapy as a risk factor for ischemic stroke (IS). [Study participants were] 309 patients with IS or transient ischemic attack undergoing long-term aspirin treatment before...
Source: Managed Care Law Weekly (2005-10-09)
|
